⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
VCYT News
Veracyte, Inc.
Form 8-K
sec.gov
VCYT
Veracyte Announces Second Quarter 2026 Financial Results
globenewswire.com
VCYT
Veracyte to Participate in Upcoming Investor Conferences
globenewswire.com
VCYT
Veracyte to Release Second Quarter 2026 Financial Results on July 30, 2026
businesswire.com
VCYT
Form 8-K
sec.gov
VCYT
Veracyte Announces Commercial Launch of the Prosigna Breast Test in the U.S.
businesswire.com
VCYT
ENZAMET Trial Shows Veracyte's Decipher Prostate Test Identifies Which Patients Benefit from Adding Chemotherapy in Metastatic Prostate Cancer
businesswire.com
VCYT
Landmark OPTIMA Trial Delivers Practice-Changing Evidence that Veracyte’s Prosigna Test Identifies Patients with High-Risk Breast Cancer Who Can Safely Avoid Chemotherapy
businesswire.com
VCYT
Veracyte to Host Investor Call on June 1, 2026 to Discuss ASCO Findings
businesswire.com
VCYT
OPTIMA Trial Results to Be Presented at ASCO Provide New Evidence Supporting Prosigna-Guided Chemotherapy Decisions in Breast Cancer
businesswire.com
VCYT